Effect of Perioperative Hydration After Rheolytic Thrombectomy for Iliofemoral Deep Vein Thrombosis

Abstract

Percutaneous pharmacomechanical thrombectomy is a preferred treatment for certain patients with acute thrombosis. Various devices have been approved for this purpose, including a rheolytic thrombectomy device (rPMT). Reported studies have noted an association between the use of an rPMT and acute kidney injury (AKI) and acute renal failure. Our objective was to determine whether an aggressive perioperative hydration strategy would minimize the potential for deleterious renal outcomes, especially in the setting of acute iliofemoral deep vein thrombosis (IF-DVT).